Prescriber section (your health-care providers responsibility) Your health-care provider must complete the second part of the application: Provide prescription details: medication name, dosage, frequency, and refill quantity Sign the Provider Declaration, stating: The medication is medically necessary It will be dispensed to you at no charge Step 5: Submit the application Once youve completed the application and gathered all required documentation, the next step is to submit it to Novo Nordisk for review
Underwriters therefore need to continue to review and assess medical evidence for any associated side effects and potential comorbidities, including cardiovascular status, renal and hepatic function, and mental health or cognitive concerns
Glucagon agonism reduces also food intake [61] and increases energy expenditure [62], suggesting that it could promote WL (Fig
For anyone with cardiovascular risk factors, and the majority of people with obesity have at least one, this distinction between a medication that raises cardiovascular stress and one that reduces it is arguably more important than the weight loss difference itself
"People living with obesity need treatment options that meet them where they are and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment," said Dr Deborah Horn, director of the Center for Obesity Medicine at McGovern Medical School at UTHealth Houston
For physically active users, they may subtly affect recovery, endurance, and performance over time